EpiCast Report: Atrial Fibrillation Epidemiology Forecast to 2023 By RnRMarketResearch
Browse more reports on Pharmaceuticals at http://www.rnrmarketresearch.com/reports/lifesciences/pharmaceuticals Š http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Atrial Fibrillation Epidemiology Forecast to 2023 Atrial fibrillation (AF) is a disorder of the heart’s electrical system. The condition is characterized by an irregular heart rhythm that is either too fast or too slow. During AF, the two upper chambers of the heart (atria) beat out of coordination with the two lower chambers (ventricles) due to disorganized electrical signals, resulting in poor blood supply to the lungs and the rest of the body. The symptoms of AF typically include heart palpitations, irregular and fast heartbeat, chest discomfort, shortness of breath, dizziness, and weakness. However, individuals with AF may be asymptomatic and not even know that they have the condition until it is identified through an electrocardiogram (EKG or ECG) test. Complete report available at http://www.rnrmarketresearch.com/epicastreport-atrial-fibrillation-epidemiology-forecast-to-2023-market-report.html . Š http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Atrial Fibrillation Epidemiology Forecast to 2023 AF is one of the most common cardiovascular diseases among the elderly, worldwide. Although AF affects people of all ages, the condition is rare in individuals younger than 40 years of age. The risk for AF increases rapidly with age and is more common in men than women. Globally, the prevalence of AF varies widely, depending on the country and the study, ranging from 0.1-1.6% in Asia (0.1% in India, 1.6% in Japan), 0.95-3.9% in North America (0.95% in the US, 3.9% in Canada), 1.28-2.1% in Europe (1.28% in the UK, 2.1% in Germany), and 4.0% in Australia.
(This is a premium report priced at US$3995 for a single user License.) Š http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Atrial Fibrillation Epidemiology Forecast to 2023 Scope: • The Atrial Fibrillation (AF) EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for AF in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Canada). It includes a 10year epidemiological forecast for the diagnosed prevalent cases of AF segmented by sex, age (in five-year age groups, beginning at 40 years and ending at =85 years), and clinical subtypes (paroxysmal, persistent, and permanent AF) in these markets. • The AF epidemiology report is written and developed by Mastersand PhD-level epidemiologists. • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
© http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Atrial Fibrillation Epidemiology Forecast to 2023 Reasons to Buy:
• Develop business strategies by understanding the trends shaping and driving the global AF market. • Quantify patient populations in the global AF market to improve product design, pricing, and launch plans. • Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for AF therapeutics in each of the markets covered.
© http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Atrial Fibrillation Epidemiology Forecast to 2023
For more details contact Mr. Ritesh Tiwari : sales@rnrmarketresearch.com / +18883915441
RnRMarkertResearch RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe.
Š http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441